Samuel Insa-Diaz

Valencia, VC, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Long-Term Effectiveness and Persistence Factors of Anti-CGRP Monoclonal Antibodies in Migraine: 2-Year Results From the EUREkA Cohort.

Long-Term Effectiveness and Persistence Factors of Anti-CGRP Monoclonal Antibodies in Migraine: 2-Year Results From the EUREkA Cohort.

Journal: Neurology

Published: May 27, 2026

Long-Term Effectiveness and Persistence Factors of Anti-CGRP Monoclonal Antibodies in Migraine: 2-Year Results From the EUREkA Cohort.

Long-Term Effectiveness and Persistence Factors of Anti-CGRP Monoclonal Antibodies in Migraine: 2-Year Results From the EUREkA Cohort.

Journal: Neurology

Published: January 28, 2026

Diagnosis and treatment of disorders of intracranial pressure: consensus statement of the Spanish Society of Neurology's Headache Study Group.

Diagnosis and treatment of disorders of intracranial pressure: consensus statement of the Spanish Society of Neurology's Headache Study Group.

Journal: Neurologia

Published: March 02, 2024

New therapeutic era for migraine attacks with recently approved monoclonal antibodies, ditans and gepants

New therapeutic era for migraine attacks with recently approved monoclonal antibodies, ditans and gepants

Journal: Revista de neurologia

Published: January 15, 2024

Redefining migraine prevention: early treatment with anti-CGRP monoclonal antibodies enhances response in the real world.

Redefining migraine prevention: early treatment with anti-CGRP monoclonal antibodies enhances response in the real world.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: December 27, 2023

Observational Retrospective Study in Patients Treated with Galcanezumab as Preventive Treatment for Migraine: The ORYGAM Study.

Observational Retrospective Study in Patients Treated with Galcanezumab as Preventive Treatment for Migraine: The ORYGAM Study.

Journal: Pain and therapy

Published: December 11, 2023

Effectiveness and safety of anti-CGRP monoclonal antibodies in patients over 65 years: a real-life multicentre analysis of 162 patients.

Effectiveness and safety of anti-CGRP monoclonal antibodies in patients over 65 years: a real-life multicentre analysis of 162 patients.

Journal: The journal of headache and pain

Published: February 09, 2023

1st Post-European Headache Federation Meeting: a review of the latest developments presented at the 2020 European Headache Federation Congress.

1st Post-European Headache Federation Meeting: a review of the latest developments presented at the 2020 European Headache Federation Congress.

Journal: Revista de neurologia

Published: June 28, 2021

Characterisation of the management of patients with migraine in the primary care setting in Spain. Analysis of the results of the European My-LIFE anamnesis project.

Characterisation of the management of patients with migraine in the primary care setting in Spain. Analysis of the results of the European My-LIFE anamnesis project.

Journal: Neurologia

Published: June 10, 2021

Document of revision and updating of medication overuse headache (MOH).

Document of revision and updating of medication overuse headache (MOH).

Journal: Neurologia

Published: February 11, 2020

Calcitonin gene-related peptide in migraine: from pathophysiology to treatment.

Calcitonin gene-related peptide in migraine: from pathophysiology to treatment.

Journal: Neurologia

Published: December 20, 2018

Calcitonin gene-related peptide in migraine: from pathophysiology to treatment.

Calcitonin gene-related peptide in migraine: from pathophysiology to treatment.

Journal: Neurologia

Published: December 20, 2018

Showing 1-12 of 16

Last Updated: 09/26/2026